Provided by Tiger Trade Technology Pte. Ltd.

Day One Biopharmaceuticals Inc.

10.11
+1.3515.35%
Volume:3.55M
Turnover:35.63M
Market Cap:1.04B
PE:-6.85
High:10.47
Open:8.80
Low:8.74
Close:8.76
52wk High:13.53
52wk Low:5.64
Shares:102.68M
Float Shares:78.77M
Volume Ratio:1.99
T/O Rate:4.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4748
EPS(LYR):-1.0243
ROE:-30.16%
ROA:-18.57%
PB:2.30
PE(LYR):-9.87

Loading ...

Day One Biopharmaceuticals CEO to Present at J.P. Morgan Healthcare Conference

Reuters
·
Dec 16

Buy Rating Affirmed for Day One Biopharmaceuticals Based on Promising Long-Term Data from FIREFLY-1 Trial

TIPRANKS
·
Nov 25

Day One Biopharmaceuticals Reveals Promising Phase 2 Trial Results

TIPRANKS
·
Nov 25

Day One Biopharm Price Target Maintained With a $16.00/Share by Needham

Dow Jones
·
Nov 24

Day One Biopharmaceuticals Reports Three-Year Data Showing Durable Responses for OJEMDA in Pediatric Low-Grade Glioma

Reuters
·
Nov 24

Day One Announces Three Year Follow-up Data From Ojemda™ (Tovorafenib) Phase 2 Firefly-1 Trial at the 2025 Society for Neuro-Oncology (Sno) Annual Meeting

THOMSON REUTERS
·
Nov 24

Press Release: Day One Announces Three Year Follow-Up Data From OJEMDA(TM) (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting

Dow Jones
·
Nov 24

BUZZ-Nasdaq biotech index hits record high, set to gain nearly 5% this week

Reuters
·
Nov 15

Mersana Therapeutics reports third quarter 2025 financial results

Reuters
·
Nov 14

Sector Update: Health Care Stocks Edge Higher Late Afternoon

MT Newswires Live
·
Nov 14

Wedbush Adjusts Price Target on Day One Biopharmaceuticals to $29 From $25, Maintains Outperform Rating

MT Newswires Live
·
Nov 14

Day One Biopharmaceuticals Inc : Piper Sandler Cuts Target Price to $25 From $26

THOMSON REUTERS
·
Nov 14

Analysts Conflicted on These Healthcare Names: Bioxcel Therapeutics (BTAI) and Day One Biopharmaceuticals (DAWN)

TIPRANKS
·
Nov 13

Oppenheimer says Day One paying up to $285M for Mersana ‘is interesting’

TIPRANKS
·
Nov 13

Day One Biopharmaceuticals Announces Mersana Acquisition Deal

TIPRANKS
·
Nov 13

Day One to Buy Mersana Therapeutics for Up to $285 Million

Dow Jones
·
Nov 13

Mersana Therapeutics Inc Proposed Deal for $25.00 per Share in Cash

THOMSON REUTERS
·
Nov 13

Mersana Therapeutics Inc - Day One to Buy Mersana for up to $285 Mln

THOMSON REUTERS
·
Nov 13

Stock Track | Day One Biopharmaceuticals Soars 5% on Promising OJEMDA Data for Pediatric Brain Cancer

Stock Track
·
Nov 10

Stock Track | Day One Biopharmaceuticals Soars 5.04% on Promising OJEMDA™ Trial Results for Pediatric Brain Cancer

Stock Track
·
Nov 10